"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."

During the past decade, Rocky Mountain Cancer Centers-Aurora conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 90 clinical trials were completed, i.e. on average, 48.9% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 63 clinical trials were completed. i.e. 88.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Aurora" #1 sponsor was "National Cancer Institute (NCI)" with 69 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "Seagen Inc." with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Aurora" #1 collaborator was "National Cancer Institute (NCI)" with 92 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "Seagen Inc." with 4 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers-Aurora" are "Breast Cancer" (10 trials), "Chronic Lymphocytic Leukemia" (10 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials) and "Stage IV Lung Cancer AJCC v8" (8 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers-Aurora" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Cancer Centers-Aurora" are "Drug" (198 trials), "Other" (110 trials), "Biological" (84 trials), "Procedure" (46 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (46 trials), "Questionnaire Administration" (26 trials), "Biospecimen Collection" (25 trials) and "Computed Tomography" (25 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Cancer Centers-Aurora" are 201 trials for "All" genders, 40 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Rocky Mountain Cancer Centers-Aurora". undefined are not yet recruiting, 61 are recruiting, 105 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 61 completed trials in Rocky Mountain Cancer Centers-Aurora, 5 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Cancer Centers-Aurora, 25 "Phase 1" clinical trials were conducted, 114 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".